ClinConnect ClinConnect Logo
Search / Trial NCT04995068

Score Predicting Lesion Development on CT Following Mild TBI

Launched by KAROLINSKA INSTITUTET · Aug 4, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Neurosurgery

ClinConnect Summary

This clinical trial is studying mild traumatic brain injury (mTBI), which is a common reason for people to visit the emergency room. The main goal of the trial is to create a scoring system that can help predict whether a patient with mTBI might develop serious brain injuries that could require surgery. Researchers will look at data from adults aged 15 and older who visited the emergency department in Stockholm, Sweden, within 24 hours of their injury and had a specific level of consciousness. They will use advanced computer models to analyze the information collected from these patients.

To participate in this study, individuals must meet certain criteria: they need to be 15 years or older, have come to the emergency department shortly after their injury, and have a specific score that indicates their level of consciousness. Participants will undergo a CT scan to check for any brain injuries. The findings from this study could help improve how doctors assess and treat patients with mTBI in the future, making it easier to identify those who may need further medical attention.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult (≥ 15 years)
  • Presented to emergency department within 24 hours of TBI
  • GCS 13-15 at presentation to the emergency department
  • Exclusion Criteria:
  • No CT scan performed
  • Patient from another Region in Sweden/another country
  • Penetrating TBI
  • Secondary transfer from other emergency department
  • Medical record missing

About Karolinska Institutet

Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.

Locations

Stockholm, Other, Sweden

Patients applied

0 patients applied

Trial Officials

Eric P Thelin, MD, PhD

Principal Investigator

Karolinska Institutet

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials